These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38967704)

  • 1. Beyond nimodipine: advanced neuroprotection strategies for aneurysmal subarachnoid hemorrhage vasospasm and delayed cerebral ischemia.
    Luzzi S; Bektaşoğlu PK; Doğruel Y; Güngor A
    Neurosurg Rev; 2024 Jul; 47(1):305. PubMed ID: 38967704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SAHIT Investigators--on the outcome of some subarachnoid hemorrhage clinical trials.
    Macdonald RL; Jaja B; Cusimano MD; Etminan N; Hanggi D; Hasan D; Ilodigwe D; Lantigua H; Le Roux P; Lo B; Louffat-Olivares A; Mayer S; Molyneux A; Quinn A; Schweizer TA; Schenk T; Spears J; Todd M; Torner J; Vergouwen MD; Wong GK; Singh J;
    Transl Stroke Res; 2013 Jun; 4(3):286-96. PubMed ID: 24323299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic Therapies for Morbidity and Mortality After Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Network Meta-Analysis of Randomized Trials.
    Dayyani M; Sadeghirad B; Grotta JC; Zabihyan S; Ahmadvand S; Wang Y; Guyatt GH; Amin-Hanjani S
    Stroke; 2022 Jun; 53(6):1993-2005. PubMed ID: 35354302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Update on the Efficacy and Safety Profile of Clazosentan in Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis.
    Song J; Xue YQ; Wang YJ; Xu P; Sun DK; Chen W
    World Neurosurg; 2019 Mar; 123():e235-e244. PubMed ID: 30496924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociation of vasospasm-related morbidity and outcomes in patients with aneurysmal subarachnoid hemorrhage treated with clazosentan: a meta-analysis of randomized controlled trials.
    Shen J; Pan JW; Fan ZX; Xiong XX; Zhan RY
    J Neurosurg; 2013 Jul; 119(1):180-9. PubMed ID: 23641823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thick and Diffuse Subarachnoid Blood as a Treatment Effect Modifier of Clazosentan After Subarachnoid Hemorrhage.
    Mayer SA; Aldrich EF; Bruder N; Hmissi A; Macdonald RL; Viarasilpa T; Marr A; Roux S; Higashida RT
    Stroke; 2019 Oct; 50(10):2738-2744. PubMed ID: 31394993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of pharmacotherapy for cerebral vasospasm and delayed cerebral ischemia after subarachnoid hemorrhage.
    Maruhashi T; Higashi Y
    Expert Opin Pharmacother; 2021 Aug; 22(12):1601-1614. PubMed ID: 33823726
    [No Abstract]   [Full Text] [Related]  

  • 8. Effectiveness of intrathecal nicardipine on cerebral vasospasm in non-traumatic subarachnoid hemorrhage: a systematic review.
    Stuart D; Christian R; Uschmann H; Palokas M
    JBI Database System Rev Implement Rep; 2018 Oct; 16(10):2013-2026. PubMed ID: 30335041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventive Effect of Clazosentan against Cerebral Vasospasm after Clipping Surgery for Aneurysmal Subarachnoid Hemorrhage in Japanese and Korean Patients.
    Fujimura M; Joo JY; Kim JS; Hatta M; Yokoyama Y; Tominaga T
    Cerebrovasc Dis; 2017; 44(1-2):59-67. PubMed ID: 28463833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnesium sulfate in combination with nimodipine for the treatment of subarachnoid hemorrhage: a randomized controlled clinical study.
    Zhang C; Zhao S; Zang Y; Zhao W; Song Q; Feng S; Hu L; Gu F
    Neurol Res; 2018 Apr; 40(4):283-291. PubMed ID: 29540123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasospasm after aneurysmal subarachnoid hemorrhage: need for further study.
    Pearl JD; Macdonald RL
    Acta Neurochir Suppl; 2008; 105():207-10. PubMed ID: 19066110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomised trial of clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid hemorrhage undergoing surgical clipping (CONSCIOUS-2).
    Macdonald RL; Higashida RT; Keller E; Mayer SA; Molyneux A; Raabe A; Vajkoczy P; Wanke I; Bach D; Frey A; Marr A; Roux S; Kassell N
    Acta Neurochir Suppl; 2013; 115():27-31. PubMed ID: 22890639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
    Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
    J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial.
    Macdonald RL; Kassell NF; Mayer S; Ruefenacht D; Schmiedek P; Weidauer S; Frey A; Roux S; Pasqualin A;
    Stroke; 2008 Nov; 39(11):3015-21. PubMed ID: 18688013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of clazosentan in patients with aneurysmal subarachnoid hemorrhage: a meta-analysis of randomized controlled trials.
    Wang X; Li YM; Li WQ; Huang CG; Lu YC; Hou LJ
    PLoS One; 2012; 7(10):e47778. PubMed ID: 23082215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of intrathecal nicardipine for aneurysmal subarachnoid hemorrhage-induced cerebral vasospasm.
    Ehtisham A; Taylor S; Bayless L; Samuels OB; Klein MW; Janzen JM
    South Med J; 2009 Feb; 102(2):150-3. PubMed ID: 19139684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study.
    Vajkoczy P; Meyer B; Weidauer S; Raabe A; Thome C; Ringel F; Breu V; Schmiedek P
    J Neurosurg; 2005 Jul; 103(1):9-17. PubMed ID: 16121967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological Prevention of Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage.
    Caylor MM; Macdonald RL
    Neurocrit Care; 2024 Feb; 40(1):159-169. PubMed ID: 37740138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Cilostazol in Prevention of Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis.
    Saber H; Desai A; Palla M; Mohamed W; Seraji-Bozorgzad N; Ibrahim M
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):2979-2985. PubMed ID: 30093204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of nimodipine on cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage treated by endovascular coiling.
    Mijailovic M; Lukic S; Laudanovic D; Folic M; Folic N; Jankovic S
    Adv Clin Exp Med; 2013; 22(1):101-9. PubMed ID: 23468268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.